Evaluation of the efficacy and safety of bazedoxifene/conjugated estrogens for secondary outcomes including vasomotor symptoms in postmenopausal women by years since menopause in the Selective estrogens, Menopause and Response to Therapy (SMART) trials. [electronic resource]
Producer: 20140317Description: 18-28 p. digitalISSN:- 1931-843X
- Dose-Response Relationship, Drug
- Double-Blind Method
- Estrogens -- administration & dosage
- Estrogens, Conjugated (USP) -- administration & dosage
- Female
- Health Status
- Hot Flashes -- drug therapy
- Humans
- Indoles -- administration & dosage
- Middle Aged
- Postmenopause -- drug effects
- Quality of Life
- Selective Estrogen Receptor Modulators -- administration & dosage
- Severity of Illness Index
- Surveys and Questionnaires
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.